MedPath

Imipramine Hydrochloride

Imipramine Hydrochloride Tablets, USP Rx Only

Approved
Approval ID

dfb470ce-c21b-09bc-e053-2995a90a74f4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 23, 2022

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Imipramine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-2730
Application NumberANDA088276
Product Classification
M
Marketing Category
C73584
G
Generic Name
Imipramine Hydrochloride
Product Specifications
Route of AdministrationORAL
Effective DateMay 23, 2022
FDA Product Classification

INGREDIENTS (1)

IMIPRAMINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 1
Code: BKE5Q1J60U
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.